Larimar Therapeutics Inc (LRMR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carole S. Ben-Maimon
Employees:
30
THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
844-511-9056

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia.

Data derived from most recent annual or quarterly report
Market Cap 166.586 Million Shares Outstanding43.269 Million Avg 30-day Volume 397.623 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.75
Price to Revenue0.0 Debt to Equity0.0 EBITDA-34.014 Million
Price to Book Value1.8717 Operating Margin0.0 Enterprise Value87.332 Million
Current Ratio14.165 EPS Growth0.71 Quick Ratio13.923
1 Yr BETA 0.8715 52-week High/Low 6.85 / 1.53 Profit Margin0.0
Operating Cash Flow Growth28.2187 Altman Z-Score7.7083 Free Cash Flow to Firm -24.869 Million
Earnings Report2023-08-10
View SEC Filings from LRMR instead.

View recent insider trading info

Larimar Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding LRMR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LRMR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-18 by CELANO MICHAEL
  • 4: filed on 2023-05-18 by BEN-MAIMON CAROLE
  • 4: filed on 2023-05-18 by TRUITT JOSEPH
  • 4: filed on 2023-05-11 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2023-05-11 by HAMILTON THOMAS EDWARD
  • 4: filed on 2023-05-11 by LEFF JONATHAN S
  • 4: filed on 2023-05-11 by THOMAS FRANK E
  • 4: filed on 2023-02-09 by Shankar Gopi
  • 3: filed on 2023-02-09 by Shankar Gopi
  • 4: filed on 2022-09-20 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Events (8k)

  • 8-K: filed on 2023-06-01:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    12.8 Thousand total shares from 3 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CELANO MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    		 112,746 2023-05-17 3

    TRUITT JOSEPH

    • Director
    		 2,750 2023-05-17 2

    BEN-MAIMON CAROLE PRESIDENT AND CEO

    • Officer
    • Director
    		 266,829 2023-05-17 3

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Director
    • 10% Owner
    • * DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
    		 0 2023-05-09 2

    LEFF JONATHAN S

    • Director
    		 0 2023-05-09 1

    THOMAS FRANK E

    • Director
    		 0 2023-05-09 1

    HAMILTON THOMAS EDWARD

    • Director
    		 0 2023-05-09 2

    SHANKAR GOPI CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2023-02-07 2

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MGMT III, L.P.

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD MGMT IV, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    • Director
    • 10% Owner
    • * DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
    		 16,941,357 2022-09-16 2

    DEERFIELD PARTNERS, L.P.

    DEERFIELD MGMT L.P.

    • Director
    • 10% Owner
    • DIR. BY DEPUTIZATION/10% GROUPDIR. BY DEPUTIZATION/10% GROUP
    		 2,777,777 2022-09-16 1

    BARRETT PETER

    • Director
    		 8,300 2022-05-10 0

    DANIEL THOMAS O

    • Director
    		 8,300 2021-05-12 0

    CHONDRIAL THERAPEUTICS HOLDINGS, LLC

    • 10% Owner
    		 No longer subject to file 2020-06-26 0

    LAMATTINA JOHN L

    • Director
    		 0 2019-06-26 0

    PEREZ ROBERT J

    • Director
    		 0 2019-06-26 0

    MCDONOUGH CAMERON GEOFFREY

    • Director
    		 0 2019-06-26 0

    EVERETT WENDY

    • Director
    		 0 2019-06-26 0

    SINGHAL PRIYA HEAD OF RESEARCH & DEVELOPMENT

    • Officer
    		 0 2019-04-02 0

    ALLEN PATRICIA L CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-01-22 0

    KIM DENNIS D CHIEF MEDICAL OFFICER

    • Officer
    		 0 2019-01-22 0

    HATFIELD JEFFREY S. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2019-01-22 0

    MCVEIGH BRIAN CHIEF BUSINESS OFFICER

    • Officer
    		 0 2019-01-22 0

    ATLAS VENTURE FUND VII L P

    ATLAS VENTURE ASSOCIATES VII, L.P.

    ATLAS VENTURE ASSOCIATES VII, INC.

    • 10% Owner
    		 No longer subject to file 2018-06-29 0

    HUGHES THOMAS E. SEE REMARKS

    • Officer
    • Director
    		 125,247 2018-06-28 0

    BOOTH BRUCE

    • Director
    • 10% Owner
    		 0 2018-01-03 0

    HELLER FRANCES K

    • Director
    		 47,961 2017-10-13 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD INTERNATIONAL MASTER FUND, L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 No longer subject to file 2016-07-20 0

    SECOR ALICIA CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2016-03-31 0

    LOUSTAU PATRICK PRESIDENT

    • Officer
    		 0 2016-03-31 0

    STARR KEVIN P

    • Director
    		 580,694 2015-09-24 0

    GOLDBERG AVI Y.

    • Director
    		 53,734 2015-09-18 0

    THIRD ROCK VENTURES LP

    THIRD ROCK VENTURES GP, L.P.

    TRV GP, LLC

    LEVIN MARK J

    TEPPER ROBERT I

    • 10% Owner
    		 No longer subject to file 2015-07-23 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    TRUITT JOSEPH - Director

    		2023-05-18 14:12:44 -0400 2023-05-17 P 2,750 $3.73 a 2,750 direct -2.9178 0.7958 0.7958 6 -3.9788 4

    BEN-MAIMON CAROLE - Director - Officer PRESIDENT AND CEO

    		2023-05-18 14:13:12 -0400 2023-05-17 P 5,000 $3.71 a 266,829 direct -2.9178 0.7958 0.7958 6 -3.9788 4

    CELANO MICHAEL - Officer CHIEF FINANCIAL OFFICER

    		2023-05-18 14:13:33 -0400 2023-05-17 P 5,000 $3.73 a 112,746 direct -2.9178 0.7958 0.7958 6 -3.9788 4

    HAMILTON THOMAS EDWARD - Director

    		2023-05-11 16:29:31 -0400 2023-05-09 A 8,300 a 8,300 direct

    LEFF JONATHAN S - Director

    		2023-05-11 16:29:14 -0400 2023-05-09 A 8,300 a 8,300 direct

    THOMAS FRANK E - Director

    		2023-05-11 16:28:50 -0400 2023-05-09 A 8,300 a 8,300 direct

    TRUITT JOSEPH - Director

    		2023-05-11 16:29:49 -0400 2023-05-09 A 8,300 a 8,300 direct

    FLYNN JAMES E - Director - > 10% Owner * DIRECTOR BY DEPUTIZATION through deerfield management company, l.p.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Director - > 10% Owner * DIRECTOR BY DEPUTIZATION through deerfield management company, l.p.

    		2023-05-11 18:31:30 -0400 2023-05-09 A 8,300 a 8,300 indirect

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 22:15:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 21:45:05 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 21:15:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 20:45:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 20:15:06 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 19:45:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 19:15:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 18:45:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 18:15:03 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 17:45:05 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 17:15:04 UTC 0.6294 4.4406 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 16:45:03 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 16:15:04 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 15:45:04 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 15:15:04 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 14:45:04 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 14:15:03 UTC 0.6619 4.4081 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 13:45:03 UTC 0.7759 4.2941 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 13:15:04 UTC 0.7759 4.2941 3100000
    LARIMAR THERAPEUTICS INC LRMR 2023-06-07 12:45:04 UTC 0.7759 4.2941 3100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments